| Q37146276 | 2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis |
| Q37217037 | A Journey in Science: The Privilege of Exploring the Brain and the Immune System |
| Q37689107 | A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry |
| Q35868821 | A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. |
| Q37611832 | A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis |
| Q47300929 | ATG-dependent phagocytosis in dendritic cells drives myelin-specific CD4+ T cell pathogenicity during CNS inflammation |
| Q42449804 | Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase |
| Q41440977 | Adoptive transfer of experimental allergic encephalomyelitis: Recipient response to myelin basic protein-reactive lymphocytes |
| Q26776191 | Advancing Cardiovascular, Neurovascular, and Renal Magnetic Resonance Imaging in Small Rodents Using Cryogenic Radiofrequency Coil Technology |
| Q35769472 | An integrated model of immunoregulation mediated by regulatory T cell subsets |
| Q40660123 | Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells |
| Q36570660 | Anti-ergotypic immunoregulation |
| Q36635307 | Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease |
| Q44732388 | Antigen-Specific Tolerance Induced by Autoimmunization with Photoinactivated Syngeneic Effector Cells |
| Q35173096 | Antigen-Specific Tolerance as a Therapy for Experimental Autoimmune Encephalomyelitis |
| Q36327373 | Antigen-specific therapies in multiple sclerosis. |
| Q24791647 | Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis |
| Q35129731 | Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins |
| Q37525926 | Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans |
| Q34600354 | Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II |
| Q35861182 | Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines |
| Q38593255 | Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications |
| Q33850715 | Autoimmune maintenance and neuroprotection of the central nervous system |
| Q35315562 | Autoimmune thyroiditis and targeted anti-T cell immunotherapy in man. |
| Q37210493 | Autologous T-cell vaccination for multiple sclerosis: a perspective on progress |
| Q37667281 | Autophagy and Autophagy-Related Proteins in CNS Autoimmunity. |
| Q35173092 | Autoreactive T Cells in Multiple Sclerosis |
| Q46181359 | Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis |
| Q36148448 | Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab |
| Q41340339 | Breakdown of self-tolerance by intrathymic injection of a T-cell line inducing autoimmune gastritis in mice |
| Q80455478 | CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE |
| Q34596822 | CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis |
| Q35940569 | CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice |
| Q35546583 | CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. |
| Q41625265 | Cell biology of autoimmune diseases |
| Q36752532 | Cell migration studies in the adoptive transfer of adjuvant arthritis in the Lewis rat. |
| Q39678803 | Cell-mediated autoimmunity in type I diabetes |
| Q40897925 | Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity-determining region-3 of a pathogenic anti-DNA monoclonal antibody |
| Q34056715 | Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines |
| Q41466292 | Characterization of brain-isolated rat encephalitogenic T cell lines |
| Q34251404 | Clinical modeling of T cell vaccination against autoimmune diseases in rats. Selection of antigen-specific T cells using a mitogen |
| Q37385073 | Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. |
| Q64996165 | Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis. |
| Q39029104 | Cytokine networks in neuroinflammation |
| Q35674246 | Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis |
| Q68810884 | Delayed type hypersensitivity (DTH) to type II collagen (CII) in DBA-1 mice |
| Q71710403 | Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis |
| Q38207555 | Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal |
| Q33780614 | Distinct levels of regulation in organ-specific autoimmune diseases |
| Q41577465 | Diverse T cell receptor beta chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein. |
| Q35173105 | EAE: a model for immune intervention with synthetic peptides |
| Q40905084 | Early rheumatoid arthritis. Future treatment |
| Q59065422 | Effector T lymphocyte line cells migrate to the thymus and persist there |
| Q72087428 | Effects of staphylococcal enterotoxin B on T cell receptor Vβ utilization and clinical manifestations of experimental allergic encephalomyelitis |
| Q35581158 | Emerging disease modifying therapies for multiple sclerosis |
| Q37559970 | Emerging immunopharmacological targets in multiple sclerosis |
| Q36868435 | Emerging therapies for MS. |
| Q67900407 | Evidence of Limited Variability of Antigen Receptors on Intrathyroidal T Cells in Autoimmune Thyroid Disease |
| Q41293419 | Experimental immunotherapies for multiple sclerosis. |
| Q44140287 | Experimental treatment of chronic lymphocytic leukemia with extracorporeal photochemotherapy. Initial observations |
| Q40435658 | Extracorporeal Photopheresis — A New Approach for the Treatment of Cutaneous T Cell Lymphomas |
| Q73086625 | Extracorporeal photochemotherapy: a historical perspective |
| Q70817704 | Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience |
| Q36203561 | Feedback regulation of autoimmunity via TCR-centered regulation |
| Q47817669 | Gammadelta T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination |
| Q48170011 | Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses |
| Q34700416 | Generalization of single immunological experiences by idiotypically mediated clonal connections |
| Q46381533 | Genetic control of experimental autoimmune encephalomyelitis at the level of cytotoxic lymphocytes in guinea pigs |
| Q35936495 | Homeostatic control of immunity by TCR peptide-specific Tregs |
| Q34200068 | Identification of cellular infiltrates during early stages of brain inflammation with magnetic resonance microscopy |
| Q39592364 | Idiotypes and autoimmunity |
| Q40115308 | Idiotypes and autoimmunity |
| Q46301718 | Immunity and the nervous system: Basic tenets |
| Q41561705 | Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease. |
| Q40437100 | Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis |
| Q38677378 | Immunological phenomena observed in the testis and their possible role in infertility |
| Q41722148 | Immunological treatment of autoimmune diseases. |
| Q41684443 | Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex |
| Q37785554 | Immunomodulatory drug treatment in multiple sclerosis |
| Q77922185 | Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview |
| Q35646266 | Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination |
| Q72695857 | Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin |
| Q40392025 | Immunotherapeutic Strategies Directed at the Trimolecular Complex |
| Q59047650 | Immunotherapy by peptides? |
| Q71607031 | Immunotherapy for multiple sclerosis: from theory to practice |
| Q38083041 | Immunotherapy of multiple sclerosis: the state of the art. |
| Q72819788 | In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis |
| Q68309825 | In vivo evidence for CD4+ and CD8+ suppressor T cells in vaccination-induced suppression of murine experimental autoimmune thyroiditis |
| Q36367554 | Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). |
| Q67862542 | Inhibition of Antiskin Allograft Immunity Induced by Infusions with Photoinactivated Effector T Lymphocytes (PET Cells). Is In Vivo Cell Transferrable? |
| Q68434385 | Inhibition of the mixed lymphocyte reaction by T cell vaccination |
| Q34546121 | Insights into the immunopathogenesis of multiple sclerosis |
| Q41138242 | Involvement of CD80 in the generation of CD4+ cytotoxic T cells. |
| Q70118422 | Is there restricted T cell receptor usage in autoimmune disease? |
| Q43407524 | Isolation and characterisation of human T-cell lines from a patient with Chagas' disease |
| Q46538947 | Isolation of myelin basic protein-reactive T-cell lines from normal human blood |
| Q33630513 | Knocking at the brain's door: intravital two-photon imaging of autoreactive T cell interactions with CNS structures |
| Q46081307 | Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients |
| Q54503292 | Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis |
| Q70053363 | Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis |
| Q34224070 | Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. |
| Q41528229 | MHC-Restricted Depletion of Human Myelin Basic Protein-Reactive T Cells by T Cell Vaccination |
| Q35838783 | Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination |
| Q35183850 | Mechanisms of action of extracorporeal photochemotherapy |
| Q40650026 | Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention |
| Q37424674 | Mechanisms of resistance to autoimmune disease induced by T-cell vaccination |
| Q68968824 | Modulation of experimental allergic encephalomyelitis (EAE): suppression of active reinduction of EAE in rats recovered from passively transferred disease |
| Q37582663 | Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis? |
| Q36703890 | Mycosis fungoides--a review of the management of 28 patients and of the recent literature |
| Q40399925 | Myelin basic protein-reactive T cells in multiple sclerosis: pathologic relevance and therapeutic targeting |
| Q73336431 | Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations |
| Q42122517 | Network regulation of autoimmunity: an automation model |
| Q38164272 | New therapeutic approaches to autoimmune disease |
| Q40486693 | On the Regulation of EAE |
| Q36370956 | Optic Neuritis, A New Variant of Experimental Encephalomyelitis, A Durable Model for All Seasons, Now In Its Seventieth Year |
| Q37526320 | Parasitic infection and autoimmunity |
| Q41540057 | Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: Functional characteristics and vaccination properties |
| Q38031780 | Photopheresis (extracorporeal photochemotherapy). |
| Q36968740 | Photopheresis: a Clinically Relevant Immunobiologic Response Modifier |
| Q36987846 | Photopheresis: a new therapeutic concept |
| Q33955168 | Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses |
| Q46730648 | Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat-shock protein |
| Q54524412 | Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptide. |
| Q40303030 | Prolongation of survival of rat cardiac allografts by T cell vaccination |
| Q36715655 | Prospects for Immunotherapy Directed to the T Cell Receptor in Human Autoimmune Disease |
| Q35936489 | Qa-1 restriction of CD8+ suppressor T cells |
| Q74233043 | Rational approaches to immune regulation |
| Q63433111 | Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases |
| Q39480719 | Regulation of autoimmune disease physiological and therapeutic |
| Q41447168 | Regulation of experimental autoimmune encephalomyelitis: Inhibition of adoptive experimental autoimmune encephalomyelitis by ‘recovery-associated suppressor cells’ |
| Q37449469 | Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy |
| Q45149123 | Regulation of retinal autoimmunity via the idiotypic network |
| Q36203550 | Regulatory T cells in autoimmune diseases: anti-ergotypic T cells |
| Q72751257 | Relevance of experimental allergic encephalomyelitis to multiple sclerosis |
| Q54361544 | Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes. |
| Q52895006 | Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations. |
| Q52895013 | Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. |
| Q67655164 | Reversal of autoimmune encephalomyelitis by membranes presenting myelin basic protein-associated class II MHC molecule as an approach to immunotherapy of organ-specific autoimmune diseases |
| Q52374508 | Reverse engineering: a model for T-cell vaccination. |
| Q79841487 | Reviving suppression? |
| Q35981635 | Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis |
| Q35721897 | Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease. |
| Q34530472 | Role of the thymus in induction and transfer of vaccination against adjuvant arthritis with a T lymphocyte line in rats |
| Q34307160 | Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis |
| Q46201877 | Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen |
| Q70128226 | Staphylococcal enterotoxin B as a potent suppressant of T cell proliferative responses in rats |
| Q67537113 | Staphylococcal enterotoxin B as a potent suppressant of T lymphocytes: trace levels suppress T lymphocyte proliferative responses |
| Q68937793 | Strategies for the modulation of neuroimmunological disease at the level of autoreactive T-lymphocytes |
| Q39302720 | Strategies for the treatment of myasthenia gravis |
| Q40838126 | Strategies for treatment of myasthenia gravis |
| Q37370531 | Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes |
| Q54385154 | Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. |
| Q71253878 | Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity |
| Q90341485 | Systematic Understanding of Bioactive Lipids in Neuro-Immune Interactions: Lessons from an Animal Model of Multiple Sclerosis |
| Q40486720 | T Cell Regulatory Circuitry: Antigen-Specific and TCR-Idiopeptide-Specific T Cell Interactions in EAE |
| Q54282778 | T Cell Vaccination in Autoimmune Diseases |
| Q48268219 | T Cell-Transfer Experimental Autoimmune Encephalomyelitis: Pillar of Multiple Sclerosis and Autoimmunity |
| Q39821470 | T cell approach to demyelinating diseases |
| Q36375972 | T cell receptor complementarity determining region 3 length analysis reveals the absence of a characteristic public T cell repertoire in neonatal tolerance. The response in the "tolerant" mouse within the residual repertoire is quantitatively simila |
| Q67294480 | T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones |
| Q36731895 | T cell receptors, immunoregulation, and autoimmunity |
| Q70567369 | T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen |
| Q71655892 | T cell regulation of collagen-induced arthritis in mice. III. Is T cell vaccination a valuable therapy? |
| Q78074655 | T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis |
| Q36359571 | T cell targeted immunotherapy for autoimmune disease |
| Q34524948 | T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial |
| Q54284373 | T cell vaccination does not induce resistance to experimental autoimmune neuritis |
| Q36887916 | T cell vaccination in multiple sclerosis |
| Q42692324 | T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study |
| Q40873787 | T cell vaccination in secondary progressive multiple sclerosis |
| Q36475992 | T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells |
| Q37398254 | T cell vaccination inhibits Th1/Th17/Tfh frequencies and production of autoantibodies in collagen-induced arthritis |
| Q40841596 | T cell vaccines for autoimmune diseases |
| Q40392456 | T cells as antigen-presenting cells |
| Q48641261 | T lymphocyte lines induce autoimmune encephalomyelitis, delayed hypersensitivity and bystander encephalitis or arthritis |
| Q72698011 | T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells |
| Q37613627 | T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis |
| Q53897545 | T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. |
| Q37580195 | T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis |
| Q77118268 | T-cell receptor peptide vaccination in the treatment of rheumatoid arthritis |
| Q39811197 | T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis |
| Q28209871 | T-cell vaccination for autoimmune disease: a panorama |
| Q28155795 | T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis |
| Q77152260 | T-cell vaccination: from basics to the clinic |
| Q37755259 | T-cell-based immunotherapy in multiple sclerosis: induction of regulatory immune networks by T-cell vaccination |
| Q35050030 | T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired |
| Q41547123 | T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. |
| Q77922223 | TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein |
| Q78008041 | Testicular-associated immune deviation: flushing of the testicular lymph sinusoids induces immunosuppression and inhibits formation of EAE in SJL mice |
| Q36924516 | The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice |
| Q36665881 | The Development of Rational Strategies for Selective Immunotherapy against Autoimmune Demyelinating Disease |
| Q37511805 | The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation |
| Q67710575 | The Potential of Restricted T Cell Recognition of Myelin Basic Protein Epitopes in the Therapy of Multiple Sclerosis |
| Q40465752 | The T-cell receptor in multiple sclerosis. |
| Q40486710 | The Ups and Downs of EAE |
| Q40490257 | The V-region disease hypothesis: new evidence suggests it is probably wrong |
| Q36560083 | The autoimmune T cell receptor: Epitopes, idiotopes, and malatopes |
| Q53989102 | The clonal composition of myelin basic protein-reactive encephalitogenic T cell populations is influenced both by the structure of relevant antigens and the nature of antigen-presenting cells. |
| Q37208525 | The gray aspects of white matter disease in multiple sclerosis |
| Q34582895 | The immunological basis for treatment of multiple sclerosis |
| Q38237315 | The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review |
| Q40403377 | The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis |
| Q40774156 | The role of thymic epithelium in the establishment of transplantation tolerance |
| Q36027486 | The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis. |
| Q40433245 | Therapeutic Regulation of T Cells in Rheumatoid Arthritis |
| Q34635952 | Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure |
| Q40518542 | Therapy for multiple sclerosis. |
| Q33713319 | Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein. |
| Q44053840 | Tolerance to experimental contact sensitivity induced by T cell vaccination |
| Q37874615 | Tovaxin for multiple sclerosis |
| Q41200073 | Treatment of Adult T Cell Leukaemia by Extracorporeal Photochemotherapy |
| Q35936500 | Tregs in T cell vaccination: exploring the regulation of regulation |
| Q44744832 | Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide |
| Q38212474 | Updating ECP action mechanisms |
| Q73794968 | Use of an alloreactive lymphocyte vaccine to prolong rat cardiac allograft survival |
| Q71064647 | Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line |
| Q37476298 | Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. |
| Q71623298 | Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL |
| Q37085898 | Vaccines for multiple sclerosis: progress to date |